Zurex Pharma, Inc. plans to complete the development and commercialization of at least three novel, proprietary antimicrobial products designed to prevent or minimize Hospital Acquired Infections and targeted for three distinct critical care areas:
- ZuraPrep™: Presurgical skin preparation for the prevention of surgical site infections (SSI).
- ZurAsept™: Prevention of intra-luminal catheter-related bloodstream infections in central line catheters.
- ZuraGard™: Prevention of extra-luminal or “exit site” wound catheter-related bloodstream infections.
New Ag Products
ZuraLac™ is specifically formulated to sanitize and protect teats from mastitis causing organisms, and protect teat skin tissue from harsh environmental conditions.
Zurex Pharma's corporate office is located in the Middleton Industrial Park. Specific comments or questions may be submitted online through our contact page.